Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 1,975.10
+12.30 (0.63%)
Sep 11, 2026, 3:29 PM IST
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 375.36 billion as of September 11, 2026. Its market cap has increased by 45.40% in one year.
Market Cap
375.36B
Enterprise Value
389.36B
Revenue
96.83B
Ranking
n/a
PE Ratio
37.09
Stock Price
1,975.10
ChartMarket Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 375.36B, an increase of 46.08%. That is a compound annual growth rate of 19.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 375.36B | 45.11% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 681.51B |
| Alkem Laboratories | 614.32B |
| Ipca Laboratories | 500.03B |
| Gland Pharma | 486.14B |
| Ajanta Pharma | 439.77B |
| Wockhardt | 360.83B |
| Piramal Pharma | 282.46B |
| Eris Lifesciences | 187.98B |